PTJ
PPH icon

Paul Tudor Jones’s VanEck Pharmaceutical ETF PPH Stock Holding History

Paul Tudor Jones’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$859K Buy
+7,860
New +$814K ﹤0.01% 2518
2025
Q4 		– Sell
-7,500
Closed -$678K – 3939
2025
Q3 		$678K Buy
+7,500
New +$657K ﹤0.01% 2522

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Paul Tudor Jones's PPH Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 7,860 shares worth $859K. The stake represents ﹤0.01% of the portfolio and ranks #2518 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in PPH as recently as Q3 2025.

Paul Tudor Jones first reported a position in PPH in Q3 2025 and has held it in 2 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Paul Tudor Jones held 7,860 shares of VanEck Pharmaceutical ETF worth $859K as of Q2 2026.
  • VanEck Pharmaceutical ETF was a new Paul Tudor Jones position in Q2 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2518 holding.
  • Paul Tudor Jones first reported a position in VanEck Pharmaceutical ETF in Q3 2025 and has held it in 2 quarters since.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.